← All companies
BIOCRYST PHARMACEUTICALS INC
BCRX - CIK 0000882796
Market cap$2.21 B
Rank#2043
SEC filings1,935
The table below shows BIOCRYST PHARMACEUTICALS INC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $171.59M | $84.08M | $88.03M | $105.19M | $96.84M | $78.41M |
| Short-term investments | $66.81M | $128.79M | $172.00M | $189.90M | - | - |
| Receivables | $109.27M | $91.33M | $91.18M | $93.39M | $72.46M | $68.76M |
| Inventory | $5.99M | $5.23M | $5.04M | $6.87M | $7.56M | $4.45M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.